Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Thanin Asawavichienjinda"'
Publikováno v:
Frontiers in Human Neuroscience, Vol 16 (2023)
IntroductionSome studies indicate a different response to treatment between migraine patients with and without aura.ObjectivesTo determine whether aura, or simple or complex aura subtypes, are clinical markers predicting response to preventive treatm
Externí odkaz:
https://doaj.org/article/0b71d2c484c24b0ab539dcc5d17e6713
Autor:
Jeerath Phannajit, Kullaya Takkavatakarn, Pisut Katavetin, Thanin Asawavichienjinda, Kriang Tungsanga, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Paweena Susantitaphong
Publikováno v:
Journal of Epidemiology and Global Health, Vol 11, Iss 3 (2021)
Objectives: This meta-analysis was conducted to investigate the current global incidence and mortality of COVID-19 and also explored the associated factors including geographic variations, transmission scenarios, country economic status, and healthca
Externí odkaz:
https://doaj.org/article/497ba94b3bf0476b9a4851b7dcb8bf84
Autor:
Kulthida Methawasin, Piyanant Chonmaitree, Chatchawan Wongjitrat, Suthee Rattanamongkolgul, Thanin Asawavichienjinda
Publikováno v:
Journal of Movement Disorders, Vol 9, Iss 1, Pp 28-34 (2016)
Objective Parkinsonism and other movement disorders have previously been reported in the acquired hepatocerebral degeneration associated with portosystemic shunting. However, there is no study to date about their prevalence as has been noted in gener
Externí odkaz:
https://doaj.org/article/8646b964464a403fa7969c8ecce6f074
Autor:
Somchai Eiam-Ong, Kearkiat Praditpornsilpa, Natthaphon Wonghakaeo, Paweena Susantitaphong, Kullaya Takkavatakarn, Jeerath Phannajit, Thanin Asawavichienjinda
Publikováno v:
Journal of Nephrology. 35:473-491
Besides reducing hyperphosphatemia in chronic kidney disease (CKD) patients, phosphate lowering agents might provide beneficial effects on clinical and laboratory parameters. This meta-analysis was conducted to comprehensively examine the impact of a
Publikováno v:
Cephalalgia. 43:033310242311612
Background A new migraine prevention, CGRP monoclonal antibodies (mAbs), is injectable on a monthly or quarterly basis. In clinical practice, some patients reported that drug effectiveness does not last until the upcoming scheduled injection, a so-ca
Publikováno v:
Asian Biomedicine. 14:139-150
Background A Thai-version of the Migraine Specific Quality of Life Questionnaire (MSQ 2.1) is available, but a qualified questionnaire used specifically for disability assessment was not available. The most relevant practical disability assessment te
Chulalongkorn Medical Journal, 66, 2, 215-222
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e54d0f9520da4f775c8899391db9605
Autor:
Jeerath, Phannajit, Natthaphon, Wonghakaeo, Kullaya, Takkavatakarn, Thanin, Asawavichienjinda, Kearkiat, Praditpornsilpa, Somchai, Eiam-Ong, Paweena, Susantitaphong
Publikováno v:
Journal of nephrology. 35(2)
Besides reducing hyperphosphatemia in chronic kidney disease (CKD) patients, phosphate lowering agents might provide beneficial effects on clinical and laboratory parameters. This meta-analysis was conducted to comprehensively examine the impact of a
Autor:
Kearkiat Praditpornsilpa, Pisut Katavetin, Kullaya Takkavatakarn, Jeerath Phannajit, Thanin Asawavichienjinda, Somchai Eiam-Ong, Kriang Tungsanga, Paweena Susantitaphong
Publikováno v:
SSRN Electronic Journal.
Introduction: Coronavirus disease 2019 (COVID-19) was first identified in December 2019 and has resulted in an ongoing pandemic. This meta-analysis was conducted to investigate the current global incidence and mortality of COVID-19 and also explore t
Publikováno v:
Asian Biomedicine. 11:331-342
Background The Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQv2.1) is used to evaluate the impact of symptoms on the quality of life (QoL) of migraineurs. Objective To evaluate primarily the concurrent validity, test–retest reliab